Compare
Charming Medical Ltd vs Marpai, Inc. vs Cryo Cell International Inc vs Sotera Health Co
| Latest fiscal year | Charming Medical Ltd MCTA | Marpai, Inc. MRAI | Cryo Cell International Inc CCEL | Sotera Health Co SHC |
|---|---|---|---|---|
| Year ended | 2026-03-31 | 2025-12-31 | 2025-11-30 | 2025-12-31 |
| Revenue | $4.81M | $18.10M | $31.57M | $1.16B |
| Revenue growth (YoY) | -22.7% | -35.8% | -1.3% | +5.7% |
| Gross margin | n/a | n/a | 76.6% (computed) | 55.5% |
| Operating margin | -0.6% | -74.9% | 1.5% | n/a |
| Net margin | -0.5% | -91.5% | -7.7% | 6.7% |
| Net income | -$22.6K | -$16.56M | -$2.43M | $77.95M |
| EPS (Diluted) | $0.00 | -$0.95 | -$0.30 | $0.27 |
| Operating cash flow | -$1.22M | -$7.45M | $5.48M | $287.19M |
| Free cash flow | -$1.56M | n/a | $5.25M | $149.18M |
| Cash & equivalents | $4.70M | $133.0K | $319.0K | $344.62M |
| Total assets | $9.87M | $10.90M | $61.73M | $3.26B |
| Total liabilities | $4.69M | $43.47M | $80.33M | $2.66B |
| Shareholders' equity | $5.18M | -$32.56M | -$18.61M | $606.03M |
| Return on year-end equity | -0.4% | n/a | n/a | 12.9% |
| Shares outstanding | n/a | 24.04M | 8.06M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Charming Medical Ltd | Marpai, Inc. | Cryo Cell International Inc | Sotera Health Co |
|---|---|---|---|---|
| Latest | $4.81M Ended 2026-03-31 | $18.10M Ended 2025-12-31 | $31.57M Ended 2025-11-30 | $1.16B Ended 2025-12-31 |
| 1 year earlier | $6.22M Ended 2025-03-31 | $28.17M Ended 2024-12-31 | $31.99M Ended 2024-11-30 | $1.10B Ended 2024-12-31 |
| 2 years earlier | $6.02M Ended 2024-03-31 | $37.16M Ended 2023-12-31 | $31.34M Ended 2023-11-30 | $1.05B Ended 2023-12-31 |
| 3 years earlier | n/a | n/a | $30.34M Ended 2022-11-30 | $1.00B Ended 2022-12-31 |
| 4 years earlier | n/a | n/a | $28.88M Ended 2021-11-30 | $931.48M Ended 2021-12-31 |